Ex situ heart perfusion: A novel platform to test cardiovascular therapeutics in human hearts
Open Access
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- AstraZeneca R&D Gothenburg
This publication has 19 references indexed in Scilit:
- Getting out of the box: the future of the UK donation after circulatory determination of death heart programmeeClinicalMedicine, 2023
- The international experience of in-situ recovery of the DCD heart: a multicentre retrospective observational studyeClinicalMedicine, 2023
- Why 90% of clinical drug development fails and how to improve it?Acta Pharmaceutica Sinica B, 2022
- Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical TrialMolecular Therapy - Methods & Clinical Development, 2020
- An acute immune response underlies the benefit of cardiac stem cell therapyNature, 2019
- Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in SwineMolecular Therapy - Methods & Clinical Development, 2018
- Preparation of viable adult ventricular myocardial slices from large and small mammalsNature Protocols, 2017
- Functional assessment and transplantation of the donor heart after circulatory deathThe Journal of Heart and Lung Transplantation, 2016
- Retrograde heart perfusion: The Langendorff technique of isolated heart perfusionJournal of Molecular and Cellular Cardiology, 2011
- 19: Serum Lactate Is a Highly Sensitive and Specific Predictor of Post Cardiac Transplant Outcomes Using the Organ Care SystemThe Journal of Heart and Lung Transplantation, 2009